289718-06-5Relevant academic research and scientific papers
Monoamine reuptake inhibitors for treatment of CNS disorders
-
, (2008/06/13)
The present invention relates to compounds of the formula wherein R1through R4, X, Y, m and n are defined as in the specification. Such compounds are useful exhibit activity as serotonin, norepinephrine and dopamine reuptake inhibito
Biaryl ether derivatives useful as monoamine reuptake inhibitors
-
, (2008/06/13)
The present invention relates to compounds of formula I, and to their pharmaceutically acceptable salts. Compounds of formula I exhibit activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of central nervous system and other disorders.
